Amelioration of Neuroinflammation, Abnormal Iron Accumulation, Oxidative Stress, and Neuronal Apoptosis via Inhibition of the NLRP3 Pathway in the Hippocampus Ameliorates Depression-Like Behavior. Here, NLRP3 is linked to depressive symptom measurement.